Navigation Links
MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
Date:12/11/2007

Three Alternative Five-day Dosing Schedules Appear Similar to Seven-Day in Achieving Red Blood Cell Transfusion Independence, Hematologic Improvement

in All MDS Patients Tested Data Presented at the 49th American Society of Hematology (ASH) Meeting

ATLANTA, Dec. 11 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) today announced interim data from a Phase 2 clinical trial evaluating three alternative five-day dosing schedules for Vidaza(R) (azacitidine for injection) that demonstrated safety and response profiles which are consistent with those achieved with the FDA-approved seven-day regimen, as reflected in rates of hematologic improvement (HI) and red blood cell (RBC) transfusion independence. These responses were observed in a broad range of MDS patients, including FAB low-risk patients. These data were presented at the 49th Annual Meeting and Exposition of the American Society of Hematology (ASH) in Atlanta.

"The data from this study suggest that a five-day schedule is as effective as the currently approved seven-day schedule at achieving RBC transfusion independence and hematologic improvement in MDS patients," said Dr. Andrew R. Allen, executive vice president and chief medical officer of Pharmion. "A dosing schedule that circumvents the need for weekend dosing would provide a meaningful benefit in terms of convenience to these patients and clinicians."

Roger M. Lyons, MD, FACP, principal investigator of the study at Cancer Care Centers of South Texas and U.S. Oncology Research San Antonio delivered an oral presentation titled "Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza) in Patients with Myelodysplastic Sy
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... -- Eight finalists, all representing outstanding innovation in pediatric ... for a chance to compete for one of two ... Second Annual Pediatric Surgical Innovation Symposium hosted by ... 24, 2014. Selected from a competitive field ... internationally, the finalists are: , Creative ...
(Date:10/16/2014)... , Oct. 16, 2014   NuVascular ... process to create new medical devices that help ... Inc., the company uses cutting-edge nanotechnology that would ... kidney diseases.  The platform technology ... result of $6.6 million in funding obtained from ...
(Date:10/16/2014)... 2014 Ninety percent of children and adults ... times or failed to respond to standard therapies went ... CTL019, developed at the Perelman School of Medicine at ... The New England Journal of Medicine ... preliminary findings presented at the American Society of Hematology,s ...
Breaking Medicine Technology:Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4Nanotechnology Venture Targets Arterial, Heart and Kidney Diseases 2Nanotechnology Venture Targets Arterial, Heart and Kidney Diseases 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 2Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 4Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 5Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 6
... Inc. (Nasdaq: BNVI ), a pharmaceutical company focused ... for women,s health and cancer, today announced the pricing of ... 30,031,200 units at a price per unit of $1.00 for ... of one share of common stock and a warrant to ...
... Information Systems ("SIS"), a leader in perioperative ... successfully completed the healthcare industry,s week-long interoperability ... Connectathon. (Logo: http://photos.prnewswire.com/prnh/20080722/SISLOGO) ... industry,s largest interoperability testing event designed to ...
Cached Medicine Technology:Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants 2Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants 3Surgical Information Systems Completes IHE North American Connectathon 2
(Date:10/19/2014)... NY (PRWEB) October 19, 2014 Nearly ... Bard Inc. and Johnson & Johnson’s Ethicon unit have ... Court, where two state proceedings are continuing to move ... 7,201 lawsuits have been filed over products part of ... Case List updated on October 11th, 2014, which showed ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 According to ... (NINDS) the vast majority of adults (up to ... point in their lives, spending at least $50 billion ... pain includes; spinal instability, stenosis, spondylolisthesis, and symptomatic degenerative ... by wear and tear associated with the aging process, ...
(Date:10/18/2014)... New Providence, NJ (PRWEB) October 19, 2014 ... service consulting company, took part in the breast cancer ... Pink is a national movement of pink pajama parties ... breast cancer survivors. , In support of the ... a group photo to the Estroven Facebook Page. In ...
(Date:10/18/2014)... natural opioid system in the brain. Now new research, ... that the opioid system of pathological gamblers responds differently ... carried out by a group of UK researchers from ... Research Council. This work is being presented at the ... a widespread behaviour with about 70% of the British ...
(Date:10/18/2014)... October 18, 2014 Mirena lawsuits ( ... to sustain serious injuries when it spontaneously migrated from ... in U.S. courts, Bernstein Liebhard LLP reports. According to ... Panel on Multidistrict Litigation (JPML) on October 15th, at ... multidistrict litigation underway in the U.S. District Court, Southern ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Litigations in New Jersey Tally More than 8,700 Lawsuits against C.R. Bard and Ethicon, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Litigations in New Jersey Tally More than 8,700 Lawsuits against C.R. Bard and Ethicon, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Litigations in New Jersey Tally More than 8,700 Lawsuits against C.R. Bard and Ethicon, Bernstein Liebhard LLP Reports 4Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 2Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 3Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 4Health News:Santa Rosa Orthopaedic (SRO) Opens the Total Spine Health Program in the North Bay – Offering Quality Care for Low Back Pain 5Health News:Stafford Communications Holds Second Annual Celebration to Raise Money for Breast Cancer 2Health News:Stafford Communications Holds Second Annual Celebration to Raise Money for Breast Cancer 3Health News:Pathological gambling is associated with altered opioid system in the brain: Reduced feeling of euphoria when compared to healthy volunteers 2Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 4
... fibrosis kills 40,000 Americans each year , , FRIDAY, May ... of the lungs that,s fatal within a few years ... , Japanese researchers say daily use of the drug ... of patients with the illness, called idiopathic pulmonary fibrosis ...
... When Jon Ziefert and Steve Smith were,recovering from ... food gift baskets. "Some were healthy but most ... ... was highly,perishable. So they had to give most of ... and other high-sugar, high-fat foods simply had no,place in ...
... 32, was indicted by a grand jury in ... the operation of an,illegal Internet pharmacy, Assistant Attorney ... U.S. Attorney Patrick L. Meehan for the,Eastern District ... charged with four counts of distribution of controlled,substances ...
... Thousands of Schoolchildren Get Active To Follow Along Online, ... top a successful,expedition to the top of the world ... of schoolchildren on the Web? Climb another,mountain? How about ... 50 states --,and do it in 50 days or ...
... the Texas Annual,Conference of the United Methodist Church will ... success of the Nothing But Nets,campaign and the groundbreaking ... The Woodlands UMC will host the event, Sunday,through Wednesday, ... May 28 at 10:45 a.m., will affirm,the covenant relationship ...
... New data, generated by Shahin Rafii and colleagues, at Weill ... human colon cancer cells and mice, have shed doubt on ... marker of colon cancer stem cells a term given ... that are thought to be able to give rise to ...
Cached Medicine News:Health News:Drug for Deadly Lung Disease Shows Promise 2Health News:Drug for Deadly Lung Disease Shows Promise 3Health News:Cancer Survivors Develop Healthy Food Gift Business 2Health News:California Man Indicted For Conspiracy In Operating Internet Pharmacy 2Health News:Denver Schoolteacher to Climb Summits of 50 States in 50 Days 2Health News:Denver Schoolteacher to Climb Summits of 50 States in 50 Days 3Health News:Local Methodists Host West African Choir, South African Leader at Historic Conference 2
... color touch screen shows you the ... cassette it is ready-to-go in any ... assures accurate calibration prior to each ... with a removable, rechargeable battery, which ...
... The ABL800 FLEX is a ... Radiometers most advanced blood gas analyzer ... that gives you the freedom to ... ABL800 FLEX provides features that are ...
Flatbed Agitator....
Flatbed Agitator....
Medicine Products: